eISSN: 1897-4252
ISSN: 1731-5530
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
4/2005
vol. 2
 
Share:
Send email
Share:
abstract:

Badania kliniczne i doświadczalne w chorobach serca, płuc i naczyń
The prognostic value of endothelin-1 precursor in patients with advanced chronic heart failure

Jolanta Nowak
,
Piotr Rozentryt
,
Tadeusz Zębik
,
Anna Majkusiak
,
Ewa Uszok-Stenzel
,
Piotr Buchta
,
Ilona Skoczylas
,
Beata Spinczyk
,
Lech Poloński
,
Marian Zembala

Kardiochir Torakochir Pol 2005; 2, 4:70-77
Online publish date: 2006/03/21
View full text Get citation
 
Introduction: It was previously reported that in patients with chronic heart failure (CHF) the plasma level of the endothelin-1 precursor (BET-1) is increased and associated with poor prognosis. Aim: The aim of the study was to assess the role of BET-1 as a predictive marker of death or urgent transplantation in patients with CHF in 3-year observation. Material and methods: Fifty seven patients with systolic CHF (52 men and 5 women, mean age 46±7 years; New York Heart Association [NYHA] class: 19-class II, 28-class III, 10-class IV) were enrolled. Mean left ventricular ejection fraction in HF patients was 23±5%. The study endpoint was performed at 3-years. Patients were subsequently stratified into those who died (n=22), received a heart transplantation (n=16) or survived (n=19). The control group consisted of 18 healthy volunteers. Plasma levels of BET-1 were analyzed in both groups, whereas basic echocardiography, standard right heart pressure measurements, peak oxygen consumption were evaluated in the study group alone. Results: Patients with CHF showed a significantly higher BET-1 concentration (median 6.3 fmol/ml, upper quartile – 7.8, lower – 4.3), as compared with the control group (median – 3.9 fmol/ml, upper quartile – 4.5, lower 3.0, p=0.002). Patients with moderate and severe CHF (NYHA III and IV) had significantly greater BET-1 values than did those with NYHA II (p<0.05). BET-1 concentration correlated positively with uric acid and CRP and negatively with peak oxygen consumption. The multivariate analysis revealed that BET-1 was neither an independent predictor of 3-year mortality nor predictor of heart worsening in patients with CHF. For these end-points only mean pulmonary artery pressure and sodium level have both retained independent predictive power. Conclusions: Our findings suggest that plasma BET-1 may be useful in the evaluation of CHF severity, but is not related to survival within 3-years clinical observation.
keywords:

endothelin-1 precursor (big endothelin-1), chronic heart failure, prognosis
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.